Safety of Linagliptin in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis

被引：0
|
作者：
Aljohani, H. [1 ]
Alrubaish, F. S. [1 ]
Alghamdi, W. [1 ]
Al-Harbi, F. [1 ]
Al-Fadel, N. [1 ]
机构：
[1] Saudi Food & Drug Author Riyadh Saudi Arabia, Drug Safety & Risk Management Dept, Riyadh, Saudi Arabia
来源：
DRUG SAFETY | 2022年 / 45卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
P072
引用
收藏
页码：1162 / 1163
页数：2
相关论文
共 50 条
  • [1] Safety of Linagliptin in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Clinical Trials
    Aljohani, Hadir
    Alrubaish, Fares S.
    Alghamdi, Waad M.
    Al-Harbi, Fawaz
    [J]. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2024, 58 (04) : 622 - 633
  • [2] The effectiveness and safety of linagliptin within elderly type 2 diabetes mellitus: a meta-analysis and systematic review
    Wang, Mengjun
    Liu, Jun-Liang
    Wang, Ning
    Han, Xuemei
    Zhang, Haixiong
    [J]. MINERVA ENDOCRINOLOGY, 2022,
  • [3] The effect of linagliptin on glycaemic control and tolerability in patients with type 2 diabetes mellitus: a systematic review and meta-analysis
    Singh-Franco, D.
    McLaughlin-Middlekauff, J.
    Elrod, S.
    Harrington, C.
    [J]. DIABETES OBESITY & METABOLISM, 2012, 14 (08): : 694 - 708
  • [4] CARDIOVASCULAR SAFETY OF SAXAGLIPTIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Mothe, R. K.
    Ganji, K.
    Esam, H.
    Likhar, N.
    Chidirala, S. R.
    Sharma, A.
    Jain, P.
    Sirumalla, Y.
    Dang, A.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A668 - A668
  • [5] Efficacy and safety of bexagliflozin in patients with type 2 diabetes mellitus: A systematic review and meta-analysis
    Pasqualotto, Eric
    Watanabe, Janine Midori Figueiredo
    Gewehr, Douglas Mesadri
    Maintinguer, Raphaela da Silva
    van de Sande-Lee, Simone
    de Araujo, Gustavo Neves
    Leal, Fidel Silveira
    Pinheiro, Carlos Eduardo Andrade
    [J]. DIABETES OBESITY & METABOLISM, 2023, 25 (07): : 1794 - 1802
  • [6] Efficacy and safety of luseogliflozin in patients with type 2 diabetes mellitus: a systematic review and meta-analysis
    Galigutta, Reddikumar Reddy
    Hasik, P. N.
    Thomas, Christy
    Undela, Krishna
    [J]. ENDOCRINE, 2024,
  • [7] A comprehensive systematic review and meta-analysis of the efficacy and safety of bexagliflozin in patients with type 2 diabetes mellitus
    Sharma, Vikas
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 261 - 262
  • [8] EFFICACY AND SAFETY OF CANAGLIFLOZIN AMONG PATIENTS WITH TYPE 2 DIABETES MELLITUS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Kaur, K.
    Likhar, N.
    Dang, A.
    [J]. VALUE IN HEALTH, 2015, 18 (03) : A56 - A57
  • [9] The efficacy and safety of evogliptin for type 2 diabetes mellitus: A systematic review and meta-analysis
    Tang, Qizhi
    Pan, Weiyu
    Peng, Liangyue
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [10] Fixed-dose combination of empagliflozin and linagliptin for the treatment of patients with type 2 diabetes mellitus: A systematic review and meta-analysis
    Katsiki, Niki
    Ofori-Asenso, Richard
    Ferrannini, Ele
    Mazidi, Mohsen
    [J]. DIABETES OBESITY & METABOLISM, 2020, 22 (06): : 1001 - 1005
12345